The Insider Charles Hill Unloaded 26779 shares of Pfizer Inc. (PFE); Last Week First American Financial (FAF) Coverage

Among 15 analysts covering First American Financial (NYSE:FAF), 8 have Buy rating, 1 Sell and 6 Hold. Therefore 53% are positive. First American Financial had 17 analyst reports since September 25, 2015 according to SRatingsIntel. The stock of First American Financial Corporation (NYSE:FAF) earned “Overweight” rating by Barclays Capital on Friday, October 27. Bernstein initiated the shares of FAF in report on Thursday, December 10 with “Mkt Perform” rating. The firm has “Sell” rating by Goldman Sachs given on Wednesday, January 13. The firm has “Outperform” rating given on Friday, December 18 by Macquarie Research. The firm has “Positive” rating given on Tuesday, October 20 by Susquehanna. The rating was upgraded by Stephens to “Overweight” on Monday, January 8. On Wednesday, October 21 the stock rating was initiated by Tigress Financial with “Buy”. The company was initiated on Friday, December 11 by Oppenheimer. The stock of First American Financial Corporation (NYSE:FAF) has “Overweight” rating given on Friday, February 12 by Barclays Capital. The firm earned “Hold” rating on Friday, November 13 by Topeka Capital Markets. See First American Financial Corporation (NYSE:FAF) latest ratings:

09/02/2018 Broker: Barclays Capital Old Rating: Overweight New Rating: Overweight Old Target: $75 New Target: $70 Maintain
08/01/2018 Broker: Stephens Old Rating: Equal-Weight New Rating: Overweight Upgrade
27/10/2017 Broker: Barclays Capital Rating: Overweight Old Target: $52 New Target: $60 Maintain

The insider, and Pfizer Inc’s Executive Vice President, Charles Hill, unloaded 26,779 company shares on March 02, 2018, worth about $986,292 (at $36.8 for share). For complete details of this sale please read the Security and Exchange Commission’s filing ready for you here. This sell decreased his ownership of the company to 0.00% total market cap or 111,135 shares.

Investors sentiment decreased to 1.02 in Q3 2017. Its down 0.65, from 1.67 in 2017Q2. It turned negative, as 29 investors sold First American Financial Corporation shares while 100 reduced holdings. 39 funds opened positions while 93 raised stakes. 90.34 million shares or 0.17% more from 90.19 million shares in 2017Q2 were reported. Aperio Ltd Limited Liability Company has 121,423 shares. Moreover, Hancock Hldg has 0.06% invested in First American Financial Corporation (NYSE:FAF). Becker Cap Mgmt stated it has 0.01% of its portfolio in First American Financial Corporation (NYSE:FAF). Nationwide Fund Advsr invested in 229,044 shares. Lpl Lc owns 0.01% invested in First American Financial Corporation (NYSE:FAF) for 28,563 shares. One Association, New York-based fund reported 33,520 shares. Massachusetts Fincl Service Ma owns 27,924 shares for 0% of their portfolio. First Personal Svcs has 0% invested in First American Financial Corporation (NYSE:FAF). Winslow Evans & Crocker accumulated 400 shares. Connor Clark & Lunn Investment Management reported 31,731 shares or 0.01% of all its holdings. Foster Motley accumulated 27,862 shares. Martingale Asset L P holds 325,454 shares or 0.22% of its portfolio. Gemmer Asset Ltd Com accumulated 198 shares or 0% of the stock. Ww Asset Management accumulated 7,615 shares. Vanguard Gp invested 0.02% of its portfolio in First American Financial Corporation (NYSE:FAF).

First American Financial Corporation, through its subsidiaries, provides financial services. The company has market cap of $6.31 billion. It operates through Title Insurance and Services, and Specialty Insurance divisions. It has a 15.12 P/E ratio. The Title Insurance and Services segment issues title insurance policies on residential and commercial property, as well as offers related services and products.

The stock increased 0.67% or $0.38 during the last trading session, reaching $56.86. About 216,721 shares traded. First American Financial Corporation (NYSE:FAF) has risen 15.34% since March 2, 2017 and is uptrending. It has underperformed by 1.36% the S&P500.

Among 22 analysts covering Pfizer (NYSE:PFE), 10 have Buy rating, 1 Sell and 11 Hold. Therefore 45% are positive. Pfizer has $54.0 highest and $33.0 lowest target. $39.80’s average target is 10.57% above currents $35.9938 stock price. Pfizer had 75 analyst reports since July 29, 2015 according to SRatingsIntel. The company was maintained on Tuesday, September 13 by Jefferies. Barclays Capital upgraded the stock to “Overweight” rating in Tuesday, November 29 report. S&P Research maintained Pfizer Inc. (NYSE:PFE) on Wednesday, October 28 with “Hold” rating. The stock of Pfizer Inc. (NYSE:PFE) has “Neutral” rating given on Friday, March 24 by Societe Generale. The rating was maintained by Piper Jaffray with “Buy” on Wednesday, August 2. Goldman Sachs maintained Pfizer Inc. (NYSE:PFE) rating on Monday, April 18. Goldman Sachs has “Neutral” rating and $35 target. The firm has “Buy” rating given on Monday, July 10 by Cowen & Co. Piper Jaffray maintained the stock with “Overweight” rating in Friday, August 28 report. The company was reinitiated on Thursday, April 7 by JP Morgan. The firm has “Neutral” rating by Morgan Stanley given on Friday, April 7.

The stock increased 1.02% or $0.3638 during the last trading session, reaching $35.9938. About 15.10M shares traded. Pfizer Inc. (NYSE:PFE) has declined 2.76% since March 2, 2017 and is downtrending. It has underperformed by 19.46% the S&P500.

Since September 12, 2017, it had 0 insider purchases, and 7 insider sales for $5.93 million activity. $2.39 million worth of Pfizer Inc. (NYSE:PFE) shares were sold by Dolsten Mikael. $353,677 worth of Pfizer Inc. (NYSE:PFE) was sold by LUND-JURGENSEN KIRSTEN. $64,679 worth of stock was sold by CORNWELL W DON on Monday, February 26. SUSMAN SALLY sold $1.24M worth of stock. JOHNSON RADY A also sold $296,560 worth of Pfizer Inc. (NYSE:PFE) on Friday, December 15. MACKENZIE ALEXANDER R sold $249,750 worth of stock.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on May, 1. They expect $0.70 EPS, up 1.45% or $0.01 from last year’s $0.69 per share. PFE’s profit will be $4.17B for 12.85 P/E if the $0.70 EPS becomes a reality. After $0.62 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts 12.90% EPS growth.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: